Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts

Published:2009-03-31 Issue:8 Volume:100 Page:1315-1319
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Huhtinen K,Suvitie P,Hiissa J,Junnila J,Huvila J,Kujari H,Setälä M,Härkki P,Jalkanen J,Fraser J,Mäkinen J,Auranen A,Poutanen M,Perheentupa A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6605011.pdf

Reference22 articles.

1. (1997) Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 67: 817–821

2. Benedet JL, Bender H, Jones 3rd H, Ngan HY, Pecorelli S (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers, FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70: 209–262

3. Drapkin R, von Horsten H, Lin Y, Mok S, Crum C, Welch W, Hecht J (2005) Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res 65: 2162–2169

4. Gagnon A, Ye B (2008) Discovery and application of protein biomarkers for ovarian cancer. Curr Opin Obstet Gynecol 20: 9–13

5. Galgano M, Hampton G, Frierson HJ (2006) Comprehensive analysis of HE4 expression in normal and malignant human tissues. Mod Pathol 19: 847–853

Cited by 240 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human epididymis protein 4: Analysis of national health and nutrition examination survey data;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-06

2. Predictive Role of HE4 in Diagnosis of Ovarian Tumors;The Journal of Obstetrics and Gynecology of India;2024-02-15

3. Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery;British Journal of Cancer;2024-01-19

4. Rare but Still There: A Scoping Review on Endometriosis-Associated Ovarian Cancer;Discovery Medicine;2024

5. Diagnostic, prognostic, and therapeutic biomarkers of ovarian cancer;Peritoneal Tumor Microenvironment of Cancers on Cancer Hallmarks;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3